I seek to understand client needs and goals, and work tirelessly to deliver options that achieve outcomes they deserve, while cultivating a relaxed, open and consultative relationship.
Tony leads the firm’s outsourced pharmaceutical services and life sciences practices, specializing in mergers and acquisitions (M&A). He has executed sell-side and buy-side M&A transactions for private equity clients, publicly traded companies and privately held and family-owned businesses.
Tony specializes in M&A for highly differentiated outsourced pharmaceutical service businesses and clinical laboratories, helping them to understand the converging and dynamic end markets, identify growth opportunities, and leverage technology to deliver cost-saving solutions. His deep experience in pharmaceutical outsourcing and laboratory markets provides unique insights to assist growing life sciences companies (diagnostics and research products) that supply laboratories, contract research organizations, and pharmaceutical/biotechnology companies with the innovative products and technologies required to remain cutting edge.
Prior to joining Lincoln, Tony was a Vice President in the healthcare investment banking practice of GCA Savvian Advisors. Previously, he was an Associate at Vector Securities International and an Analyst in the Healthcare Corporate Finance group of RBC Capital Markets (formerly Dain Rauscher Wessels).
Tony earned a Bachelor of Science from the Carlson School of Management at the University of Minnesota.
Lincoln International is pleased to announce the sale of BioAgilytix, a portfolio company of Riverside Partners, to Cobepa S.A.
Lincoln International represents Firma Clinical Research in its sale to Northlane Capital Partners
Lincoln International represents Sekisui Medical Co., Ltd, Sekisui Chemical Co., Ltd. in the sale of Sekisui Virotech GmbH to Virotech Diagnostics Holdings GmbH
Lincoln International represents Baylor College of Medicine in the announced transaction between Medical Genetics Laboratories and Miraca Holdings Inc.
Lincoln International represents the University of Kentucky Research Foundation in the sale of Coldstream Laboratories, Inc. to Piramal Enterprises Limited
Lincoln International advises Corning Inc. on the acquisition of Gerresheimer AG’s pharmaceutical glass tubing business
Lincoln International represents Incline Equity Partners in the sale of Wheaton Industries to Duran Group
Meet our Senior Team
I work hand in hand with clients to help drive business improvements and strategic positioning.